PLOS
When family members of patients with colorectal cancer are invited to screening appointments themselves, just 1 in 3 go ahead with either fecal testing or colonoscopy, representing missed opportunities for early detection, according to a clinical trial conducted by researchers in Spain.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
